EPO Antikörper
Kurzübersicht für EPO Antikörper (ABIN6295990)
Target
Alle EPO Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Mouse anti-Human Erythropoietin Antibody / EPO [Sodium Azide Free]
-
Spezifität
- Cell surface, cytoplasmic
-
Aufreinigung
- A human partial recombinant protein was used as the immunogen for the EPO antibody.
-
Immunogen
- A human partial recombinant protein was used as the immunogen for the EPO antibody.
-
-
-
-
Applikationshinweise
-
WB: 0.5-1 μg/mL
IF: 1-2 μg/mL
Immunohistochemistry (FFPE): 4-8 μg/mL for 30 min at RT (1)
Flow Cytometry: 0.5-1 μg/million cells in 0.1ml -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- EPO (Erythropoietin (EPO))
-
Andere Bezeichnung
- Erythropoietin
-
Substanzklasse
- Hormone
-
Hintergrund
-
Target Description: Erythropoietin / EPO is a secreted, glycosylated cytokine hormone composed of four alpha helical bundles. It is the primary factor responsible for regulating erythropoiesis during steady-state conditions and in response to blood loss and hemorrhage in the adult organism. Erythropoietin is synthesized by the kidney and stimulates the proliferation and maturation of bone marrow erythroid precursor cells. The protein is found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis.
Gene Symbol: EPO
-
Gen-ID
- 2056
-
UniProt
- P01588
-
Pathways
- JAK-STAT Signalweg, Hormone Activity, Negative Regulation of intrinsic apoptotic Signaling, Negative Regulation of Transporter Activity
Target
-